Introduction
The inhibitory neurotransmitter ␥-aminobutyric acid (GABA) activates both ionotropic GABA A receptors and metabotropic GABA B receptors. GABA A receptors are Cl Ϫ ion channels that produce electrical signals when activated. GABA A receptors respond transiently to GABA released from synaptic vesicles and, in many areas of the brain including the hippocampus, high-affinity GABA A receptors at extrasynaptic sites are activated tonically by ambient GABA (Farrant and Nusser, 2005; Glykys and Mody, 2007) . Activation of presynaptic and postsynaptic GABA B receptors stimulates intracellular G-protein signaling cascades that activate K ϩ channels, inhibit voltage-gated Ca 2ϩ channels, and regulate cyclic AMP (cAMP) and protein kinase A (PKA) (Padgett and Slesinger, 2010) . Because postsynaptic GABA B receptors are located at extrasynaptic sites away from GABA release sites, their activation is limited by GABA uptake and requires patterns of presynaptic activity that lead to GABA spillover and elevations of ambient GABA (Scanziani, 2000; Kulik et al., 2003) .
Under conditions of increased ambient GABA, such as occur with ischemia, epileptic seizures, or drugs that increase GABA concentration, coactivation of GABA A receptors and postsynaptic GABA B receptors will occur (Scanziani et al., 1991; During and Spencer, 1993; Wu et al., 2003; Allen et al., 2004) .
In dentate gyrus granule cells (DGGCs), electron microscopy with immunogold labeling has identified GABA B receptors at perisynaptic sites on dendritic and somatic membranes (Kulik et al., 2003) , a distribution pattern that has remarkable overlap with the distribution of extrasynaptic GABA A receptor subunits that mediate tonic inhibition in DGGCs (i.e., ␦ subunits) (Wei et al., 2003) . The proximity of postsynaptic GABA B receptors to extrasynaptic GABA A receptors on DGGCs suggests that GABA A receptors will be exposed to intracellular signaling pathways activated by GABA B receptors. This potential interaction has likely been overlooked, because studies of GABA A receptors are routinely done in the presence of GABA B receptor antagonists.
We investigated the interaction between GABA B receptors and GABA A receptors in DGGCs. Our data show that activation of postsynaptic GABA B receptors enhances GABA A currents caused by exogenous GABA. This newly identified interaction was not present in CA1 pyramidal neurons or layer 2/3 cortical pyramidal neurons. In DGGCs, tonic GABA currents and currents mediated by ␦ subunit-containing receptors were also modulated by GABA B receptor activation. Our results indicate that extrasynaptic GABA A receptor function will be enhanced when postsynaptic GABA B receptors are activated, increasing the inhibitory tone of DGGCs.
Materials and Methods
Brain slice preparation. Brain slices were prepared from 4 -6 week old Sprague Dawley rats of both sexes. Rats were anesthetized with 4% isoflurane, decapitated, and the brain dissected free. Transverse hippocampal slices (300 m) were prepared. These slices contained portions of temporal cortex that were used for experiments on cortical neurons. Slices were cut and stored in a solution containing (in mM): 125 NaCl, 3 KCl, 26 NaHCO 3 , 1.2 NaH 2 PO 4 , 0.5 CaCl 2 , 4 MgCl 2 , 20 dextrose, and 1 kynurenic acid. Slices were cut in ice-cold solution and stored at room temperature. Solutions were continuously gassed with 95% O 2 /5% CO 2 . Slices were allowed to recover for 1 h before recording. All animal use protocols were approved by the local Institutional Animal Care and Use Committee.
Electrophysiology. Membrane currents were recorded using whole-cell patch clamp techniques. Neurons were visualized with an Axioskop 2 upright microscope with fixed stage (Carl Zeiss). Recordings were made using an Axopatch 200B amplifier, a Digidata 1200 series A-D converter, and pClamp 9 software (Molecular Devices). Data were acquired at 2 kHz and low-pass filtered at 1 kHz. Series resistance was compensated by 50 -70% online. If series resistance exceeded 20 M⍀ or changed by Ͼ20%, the experiment was discarded. Focal application of GABA or bicuculline was made by pressure ejection (Picospritzer II, General Valve) from a patch pipette containing (in mM): 150 NaCl, 3 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 dextrose, and 10 HEPES with pH adjusted to 7.4 with NaOH. The pressure ejection pipette was positioned ϳ20 -30 m from the soma. The recording chamber was continuously superfused at ϳ2-2.5 ml/min with a bath solution containing (in mM): 134 NaCl, 3 KCl, 1.4 NaH 2 PO 4 , 24 NaHCO 3 , 10 dextrose, 2 MgCl 2 , 2 CaCl 2 , and 1 kynurenic acid (pH 7.35-7.4 when bubbled with 95% O 2 /5% CO 2 ). Osmolarity was adjusted to 300 -305 mOsm with H 2 O. Patch pipettes were pulled from borosilicate glass with filament (Sutter Instrument). Pipettes had resistances of 3-4 M⍀ when filled with intracellular solution containing (in mM): 125 CsCl, 10 QX-314 chloride, 10 HEPES, and 1 EGTA (pH corrected to 7.25 with CsOH). Osmolarity was adjusted to 275-285 mOsm with H 2 O as needed. Data acquisition was started 4 -6 min after establishing a whole-cell recording. Experiments were performed at room temperature (ϳ23°C). All chemicals were purchased from Sigma except SKF 89976a (Tocris-Cookson) and QX-314 (Alomone Labs). Baclofen was used at 20 M (Dutar and Nicoll, 1988) , and CGP55845 was used at 10 M (Chen and Regehr, 2003) .
Analysis. Data analysis was performed with Clampfit (pClamp 10) and Origin (v6.1, Microcal Software) software. Tonic currents were measured as the change in holding current caused by the GABA A receptor antagonist bicuculline methiodide (40 M), based on Gaussian fits to all-points current amplitude histograms constructed from 2-10 s of data with a bin width of 1 pA. Fits were performed using a Levenberg-Marquardt algorithm in Clampfit, and the holding current was taken as the center of the Gaussian curve. IPSCs were analyzed using template matching event detection. Data are presented as mean Ϯ standard error of the mean (SEM), and all error bars represent SEM. Statistical analyses were performed using Microsoft Excel. A two-tailed, paired or homoscedastic Student's t test was used with a p value Յ 0.05 considered as significant.
Results

GABA B receptor activation enhanced GABA A receptor currents in a cell type-specific manner
To investigate an interaction between metabotropic GABA B receptors and ionotropic GABA A receptors, we made focal applica- tions of GABA (10 M) to activate GABA A currents in DGGCs (V m ϭ Ϫ60 mV). Bath application of the GABA B receptor agonist baclofen (20 M) increased GABA-evoked currents by 83 Ϯ 18% (control, Ϫ358 Ϯ 143 pA vs baclofen, Ϫ577 Ϯ 184 pA, n ϭ 5, p Ͻ 0.01) (Fig.  1A) . Currents in the presence of baclofen were inhibited by bicuculline (20 M) to a similar extent as under control conditions (control, 91 Ϯ 2% inhibition, baclofen, 95 Ϯ 1% inhibition, n ϭ 3-4, p ϭ 0.26), indicating that currents enhanced by baclofen were also mediated by GABA A receptors (data not shown). Modulation of GABA A currents by baclofen was blocked by the GABA B receptor antagonist CGP55845 (CGP, 10 M). In the presence of CGP, GABA A currents were Ϫ521 Ϯ 120 pA at baseline and Ϫ486 Ϯ 138 pA after application of baclofen (n ϭ 5, p ϭ 0.38) (Fig. 1B) . These data indicate that activation of GABA B receptors augments GABA A receptor function in DGGCs. CGP by itself reduced GABA A currents, demonstrating baseline activation of GABA B receptors (and modulation of GABA A receptors) during application of GABA. On average, CGP alone reduced GABA A currents from Ϫ309 Ϯ 87 pA to Ϫ187 Ϯ 62 pA (n ϭ 5, p Ͻ 0.05) (Fig. 1C) .
We tested the effects of baclofen on GABA-evoked currents in hippocampal CA1 pyramidal cells and cortical layer 2/3 pyramidal cells. In contrast to results from DGGCs, baclofen did not modulate GABA A currents in these other cell types (CA1: control Ϫ669 Ϯ 173 pA vs baclofen Ϫ647 Ϯ 163 pA, n ϭ 4, p ϭ 0.19; Layer 2/3: control Ϫ457 Ϯ 103 pA vs baclofen Ϫ445 Ϯ 96 pA, n ϭ 6, p ϭ 0.28) (Fig. 1D) .
Modulation of GABA A current required postsynaptic G-protein activation Bath-applied baclofen activates both presynaptic and postsynaptic GABA B receptors, raising the possibility of an indirect action (e.g., via modulation of GABA release). Because GABA B receptors are G-protein coupled, transduction of receptor activation requires guanine nucleotide exchange. This process involves dissociation of GDP from inactive G proteins and binding of GTP. Thus, postsynaptic GABA B receptor signaling can be prevented by intracellular GDP-␤-S, a nonhydrolyzable GDP analog (Harayama et al., 1998; Lin and Dun, 1998) . We recorded GABA A currents from DGGCs with intracellular solutions containing GDP-␤-S (0.5 mM) and no GTP (Fig. 2A) . Intracellular GDP-␤-S prevented baclofen-induced potentiation of GABA A currents (control, Ϫ615 Ϯ 141 pA vs baclofen, Ϫ532 Ϯ 118 pA, n ϭ 5, p ϭ 0.12) (Fig. 2A) . These results indicate that baclofen modulates GABA A currents via postsynaptic GABA B receptors and a G-protein signaling pathway.
Modulation of GABA A current was independent of synaptic vesicle release Although changes in GABA release were not predicted to affect responses to exogenous GABA, we wished to exclude a contribution of vesicular GABA release to the effects of baclofen. To address this issue, we inhibited vesicular release of GABA by pretreating slices with the H ϩ -ATPase inhibitor concanamycin A (ConA, 0.5 M, 2 h). ConA treatment reduced the frequency of spontaneous IPSCs (sIPSCs) by 75% (n ϭ 9, p Ͻ 0.05) (data not shown). However, ConA treatment did not affect the baclofeninduced potentiation of GABA A currents (control, Ϫ437 Ϯ 157 pA vs baclofen, Ϫ974 Ϯ 167 pA, n ϭ 5, p Ͻ 0.01) (Fig. 2B ).
Baclofen potentiated tonic GABA A receptor currents, but not synaptic GABA A receptor currents The data presented above show that postsynaptic GABA B receptors can potentiate GABA A currents elicited by exogenous GABA. Distinct types of GABA A receptors with unique subunit compositions are transiently activated at synapses by vesicular GABA release or tonically activated by ambient GABA at extrasynaptic sites (Farrant and Nusser, 2005) . To determine whether extrasynaptic GABA A receptors were subject to modulation by postsynaptic GABA B receptors, we measured tonic GABA A current as the change in holding current caused by focal application of bicuculline (40 M). Similar to its effect on exogenous GABA currents, baclofen potentiated tonic currents (control, Ϫ7.5 Ϯ 1 pA vs baclofen, Ϫ15.2 Ϯ 0.1 pA, n ϭ 5, p Ͻ 0.01) (Fig. 3 A, B) . Tonic currents were unaffected by baclofen in the presence of CGP (CGP, Ϫ5.5 Ϯ 1.2 pA vs baclofen/CGP, Ϫ4.8 Ϯ 0.9, p ϭ 0.44, n ϭ 5) (Fig. 3C) . In contrast to GABA-evoked currents, CGP alone did not affect tonic currents (control, Ϫ13.6 Ϯ 3.0 pA vs CGP, Ϫ15.3 Ϯ 3.4, n ϭ 4, p ϭ 0.17) (Fig. 3C ). This indicates that GABA B modulation of tonic currents is not basally active and requires periods of increased ambient GABA (such as periodic application of exogenous GABA, i.e., Fig. 1C ). Following inhibition of GABA uptake by SKF 89976a (SKF, 30 M) to increase ambient GABA and tonic current, blocking GABA B receptors with CGP significantly reduced tonic current (from Ϫ86.8 Ϯ 17.9 pA to Ϫ45.9 Ϯ 9.6 pA, n ϭ 5, p Ͻ 0.01) (Fig. 3 D, E) . These data indicate that GABA B receptors modulate GABA A receptors that mediate tonic currents.
Tonic currents in DGGCs are primarily mediated by ␦ subunit-containing GABA A receptors (Glykys et al., 2008) . To confirm that baclofen potentiates currents produced by ␦ subunit-containing GABA A receptors, we used the ␦ subunitselective agonist THIP (10 M). Baclofen increased currents evoked by THIP (control, Ϫ103 Ϯ 19 pA vs baclofen, Ϫ167 Ϯ 32 pA, n ϭ 5, p Ͻ 0.05) (Fig. 4A) . In the presence of CGP, baclofen had no effect on THIP-induced currents (CGP, Ϫ48 Ϯ 13 pA vs baclofen/CGP, Ϫ46 Ϯ 14 pA, p ϭ 0.56, n ϭ 5) (Fig. 4B) . Similar to tonic currents, CGP alone did not affect THIP currents (control, Ϫ85.5 Ϯ 18.9 pA vs CGP, Ϫ 88.0 Ϯ 19.3 pA, n ϭ 4, p ϭ 0.50) (Fig. 4B ). These results demonstrate that ␦ subunit-containing GABA A receptors are a target of postsynaptic GABA B receptors.
Measurements of sIPSCs showed that baclofen reduced their frequency to 52 Ϯ 6% of control values (n ϭ 5, p Ͻ 0.05) but did not significantly affect sIPSC amplitude, 10 -90% rise times, or decay times (n ϭ 5, p ϭ 0.94, 0.44, and 0.30, respectively) (data not shown). CGP alone did not affect sIPSC frequency, amplitude, or decay times ( p ϭ 0.53, 0.52, and 0.33, respectively; n ϭ 4). These data indicate that GABA B receptors reduce presynaptic release of GABA but do not alter the properties of GABA A receptors activated at synapses (Otis and Mody, 1992).
Discussion
Our results show for the first time that postsynaptic GABA B receptors can modulate GABA A receptor function. Specifically, our data indicate that postsynaptic GABA B receptors enhance the function of GABA A receptors that produce tonic currents in DGGCs (including ␦ subunit-containing receptors). Because postsynaptic GABA B receptors and the GABA A receptors they modulate are located extrasynaptically (Kulik et al., 2003; Wei et al., 2003) , both types of receptors will experience similar levels of ambient GABA. Coactivation of these receptors during periods of increased ambient GABA associated with intense neural activity may represent a feedback mechanism to increase inhibitory tone of DGGCs (Scanziani et al., 1991; During and Spencer, 1993; Scanziani, 2000) .
Mechanism of GABA B receptor modulation of GABA A currents
Several lines of evidence indicate that GABA A currents were modulated by postsynaptic GABA B receptors. The use of exogenous GABA to activate GABA A currents would minimize effects of altered GABA release due to presynaptic GABA B activation, and GABA B effects were seen after inhibition of vesicular GABA release with ConA. Altered GABA uptake caused by presynaptic GABA B receptor activation could potentially account for our observations. However, this is unlikely because GABA B effects were seen in the presence of the GAT1 antagonist SKF. Additionally, currents produced by the nontransported GABA A agonist THIP were potentiated by baclofen, indicating that GABA B receptors enhance GABA A currents independently of GABA uptake mechanisms (including GAT3). Finally, selectively inhibiting postsynaptic G proteins by including GDP-␤-S in our pipette solutions blocked the effects of GABA B receptor activation, confirming a postsynaptic site of action.
Our data show that tonic currents caused by ambient GABA are modulated by postsynaptic GABA B receptors. Experiments using the ␦ subunit-selective agonist THIP (Mortensen et al., 2010; Meera et al., 2011) confirmed that receptors containing ␦ subunits were potentiated by GABA B receptors. GABA B receptor activation did not change sIPSC amplitude or kinetics but reduced sIPSC frequency, indicating that postsynaptic GABA B receptors did not modulate GABA A receptors activated at synapses. Because a large number of "synaptic-type" GABA A receptors (i.e., ␥ subunit containing) are located away from synapses in extrasynaptic membranes (near postsynaptic GABA B receptors) (Farrant and Nusser, 2005) , our data do not exclude the possibility that GABA B receptors modulate these types of GABA A receptors in addition to ␦ subunit-containing receptors.
Signals mediated by postsynaptic GABA B receptors are transduced by the G proteins G i /G o and G ␤␥ (Padgett and Slesinger, 2010) . A downstream effect of G ␤␥ is K ϩ channel activation; however, this is unlikely to have contributed significantly to our results because control currents and currents in the presence of baclofen were both inhibited Ͼ90% by GABA A antagonists, and intracellular QX314 effectively blocks GABA B -activated K ϩ channels (Nathan et al., 1990; Andrade, 1991) . Activation of G i /G o inhibits adenylate cyclase, with subsequent reduction in cAMP levels and reduced activation of PKA. Our data show that inhibition of G-protein signaling prevented GABA B receptor modulation of GABA A currents. The final effect on GABA A receptors is not known, but the possibilities include increased single channel conductance, open probability, or surface expression. Future studies using different experimental methods are required to distinguish between these possibilities.
Cell type specificity of the postsynaptic GABA B -GABA A interaction In DGGCs, activation of GABA B receptors substantially increased GABA A currents by 83% on average. This strong modulation was absent in CA1 pyramidal neurons and cortical layer 2/3 pyramidal neurons. One salient difference between DGGCs and CA1 pyramidal cells is that tonic inhibition in CA1 pyramidal cells is mediated by ␣5 subunit-containing GABA A receptors, whereas ␦ subunit-containing receptors are dominant in DGGCs (Caraiscos et al., 2004; Glykys et al., 2008) . In layer 2/3 pyramidal neurons there is little, if any, functional expression of ␦ subunits (although ␦ subunit mRNA is present) (Yamada et al., 2007) . Thus, we speculate that signals produced by postsynaptic GABA B receptors may preferentially affect ␦ subunits. Our results showed that baclofen did not affect sIPSC characteristics but potentiated tonic currents and THIP-evoked currents, consistent with a selective modulation of ␦ subunit-containing receptors by postsynaptic GABA B receptors. However, other factors in addition to differences in GABA A receptor subunit expression may also contribute to the cell type specificity of GABA B receptor effects.
Functional implications
Tonic inhibition affects neuronal excitability and network behavior (Chadderton et al., 2004; Glykys and Mody, 2006; Pavlov et al., 2009; Duguid et al., 2012) , thereby influencing many physiologic and pathophysiologic processes, including synaptic plasticity and epileptic seizures (Maguire et al., 2005; Martin et al., 2010) . The effect of tonic inhibition is generally inhibitory, but in some cell types (i.e., thalamocortical cells) increasing tonic inhibition is maladaptive and contributes to pathologic patterns of neuronal firing (Cope et al., 2009) . Our results add to the ways that tonic inhibition can be modulated, including GABA uptake and release by transporters, drugs that increase GABA concentrations, voltage-dependent modulation of extrasynaptic GABA A receptors, and neurosteroids (Overstreet and Westbrook, 2001; Nusser and Mody, 2002; Stell et al., 2003; Wu et al., 2003; Pavlov et al., 2009; Ransom et al., 2010) . The enhancement of tonic inhibition by postsynaptic GABA B receptors described here is predicted to reduce cellular excitability of DGGCs by shunting excitatory synaptic currents and raising action potential threshold (Stell et al., 2003; Holter et al., 2010; Arima-Yoshida et al., 2011; Gupta et al., 2012) .
